GSK plc is one of the more closely watched names within the FTSE 100, and the 1.17% decline puts the stock firmly on the day's UK market radar. The move needs to be viewed in the context of a difficult session for riskAssetsrather than …
Smith+Nephew plc is one of the more closely watched names within the FTSE 100, and the 1.23% decline puts the stock firmly on the day's UK market radar. The move needs to be viewed in the context of a difficult session for riskAssetsrather than …
EKF is a medical diagnosticsBusinessthat operates through two main divisions. Its Point-of-Care unit supplies analysers and consumables for hematology, diabetes and lactate testing, while its Life Sciences arm produces enzymes and reagents, including beta-hydroxybutyrate (β-HB) products, and provides fermentation and contractManufacturingservices. The company has …
With full interim results expected, investors following healthcare technology names on the FTSE AIM All Shareindexare watching to see whether that momentum is reflected in the detailed figures.
ECO Animal Health develops, registers and markets medicines for livestock, with a particular focus on the pig and poultry sectors. Its best-known product is Aivlosin, a veterinary antibiotic used to treat respiratory and enteric diseases in farm animals, which is sold in many countries …
EDX Medical develops and supplies digital diagnostic products and services aimed at the earlier detection and treatment of major diseases. It was founded by Professor Sir Christopher Evans and is led by chief executive Dr Mike Hudson. The group runs its own facilities in …
For investors following smaller healthcare names on London's junior market, the combination of growth, restructuring and new funding has placed the group firmly back in focus.
CRISM is focused on ChemoSeed, a technology designed to deliver chemotherapy directly into the brain. Its lead programme places implants containing the established cancer drug irinotecan into the cavity left after surgical removal of a tumour, with the aim of treating residual cancer cells …
Cambridge Nutritional Sciences describes itself as a specialist medical diagnosticsBusinessfocused on a personalised and functional approach to health and nutrition. It develops and manufactures diagnostic tests, including food sensitivity products, and sells them through distributors and partners across a number of international markets. The …
Coiled Therapeutics is a clinical-stage drug developer focused on oncology. Its lead asset, AO-252, is an experimental cancer therapy being tested in an early-stage clinical trial. The company was created through a transaction involving Roquefort Therapeutics, which had been listed on London's Main Market. …